Agoracom Blog Home

Posts Tagged ‘smallcap’

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 8:19 AM on Saturday, September 25th, 2021

A weekly summary of Novamind news and media, including the announcement of our inclusion in the NYSE Listed AdvisorShares Psychedelics ETF and more.

September 21, 2021

Burnout and the wounded healer​

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by Dr. Paul Thielking. Paul is a psychiatrist, zen practitioner, and Chief Scientific Officer at Novamind. They discuss healthcare provider burnout and other unique challenges of being in the helping/healing professions.

Learn more, subscribe and catch up on previous episodes you may have missed at psychedelictherapyfrontiers.com

View all media

Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF​

We are pleased to announce that we have been included in the AdvisorShares Psychedelics ETF trading on the NYSE under the ticker “PSIL” (the “ETF”).

PSIL is the first U.S.-listed, actively managed exchange traded fund to deliver dedicated investment exposure to psychedelics. PSIL seeks long-term capital appreciation by investing in the rapidly evolving psychedelics space, offering exposure to companies which the ETF’s portfolio manager views as leading the way in this nascent industry. The ETF currently includes 22 psychedelics companies. 

“The inclusion of Novamind in the AdvisorShares Psychedelics ETF is an important achievement for our Company,” commented Yaron Conforti, CEO and Director of Novamind. “Our clinics and clinical research sites are growing rapidly, and we are pleased to be recognized as a leading company in the emerging psychedelics sector.” 

Additional information on the ETF can be found here.

September 20, 2021

Novamind to Present at Benzinga Healthcare Conference​

Novamind to be featured in panel discussion on the disruptive potential of psychedelic medicine in mental healthcare

We will participate in the Benzinga Healthcare Small Cap Conference taking place virtually on September 29-30, 2021.

Novamind’s CEO and Director, Yaron Conforti, will join a panel of industry leaders for a discussion titled, “Addressing Mental Health through Emerging Therapies” on Thursday, September 30 at 12:35 PM EST.

Following the panel, from 1:15 PM to 1:30 PM EST, Mr. Conforti will deliver a presentation to update investors on the Company’s rapidly growing network of psychiatry clinics and clinical research sites focused on psychedelic medicine. A short Q&A session will follow.

For more information about the event and to register for free, visit: www.benzinga.com/events/small-cap/healthcare/

September 23, 2021

Novamind Announces DTC Eligibility for its Common Shares​

We are pleased to announce that our common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”) in the U.S.

The DTC is a subsidiary of the Depository Trust & Clearing Corporation, a U.S. company that manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through DTC are considered ‘DTC eligible’. This electronic method of clearing securities speeds up the receipt of stock and cash and accelerates the settlement process for investors and brokers. 

“We are pleased to have become DTC eligible. Investors will benefit from the accelerated settlement process and ability to trade Novamind shares through a wide range of U.S. brokerage firms,” said Yaron Conforti, Chief Executive Officer and Director of Novamind. “This is an important step towards increased liquidity for our stock and building a strong presence for Novamind in the U.S. capital markets.”

September 24, 2021

View all press releases

Mental Health, With a Side of Psychedelics?

A recap of some of the most promising psychedelic drugs for mental health and some of the trailblazers paving the way for the psychedelic revolution. “Sleep, exercise, therapy and antidepressants are some of the top remedies prescribed to assist the 1 in 4 Americans who struggle with mental health issues. But while these are all critical and effective tools, are they enough?”

Psychedelics Are a Billion-Dollar Business, and No One Can Agree Who Should Control It

Novamind’s business model was structured to be drug agnostic. We want to be able to provide the best possible therapies for our clients, regardless of what therapies they end up needing. It’s why we’re a champion for increasing access to all psychedelics. In this article, Shayla Love covers how those interested in psychedelics are learning to work together for the greater good. 

Follow @novamind_inc on Instagram

For further information, email us: 
[email protected]

VIDEO – Kidoz (KIDZ: TSXV) To Address The Lucrative Teens and Parents Segment of Soon To Be $400B Mobile Ad Market

Posted by AGORACOM-JC at 4:07 PM on Tuesday, September 21st, 2021

Kidoz (KIDZ: TSXV) owns the biggest mobile advertising platform for kids and families. How big? There are almost 4,000 apps around the world using Kidoz, reaching over 300 MILLION kids. The company works with top brands, including Disney, McDonald’s, Hasbro, and Lego, and is a trusted partner of Apple and Google.  

We sat down with Kidoz Inc. Co-CEOs Jason Williams & Eldad Ben Tora to discuss the entrance into lucrative teens and parents segment of soon to be $400 BILLION Mobile Ad Market. 

We discuss: 

  • New markets
  • Anticipated growth
  • Agencies that have already booked
  • +more

Q2 2021 highlights include:

  • Total Revenue of $2,177,505 – growth of 196% compared to Q2 2020 Total Revenue of $736,827.
  • AdTech revenue of $2,120,500 – growth of 247% compared to Q2 2020 AdTech Revenue $611,709.
  • Gross Profit of $1,024,333 – growth of 214% compared to Q2 2020 Gross Profit of $325,769.
  • EBITDA of $48,079 a 124% improvement from an EBITDA loss of ($197,057) in Q2 2020.

Sit back, relax and watch this powerful interview.

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 9:22 AM on Saturday, September 18th, 2021

A weekly summary of Novamind news and media, including the announcement of our selection as a research site for Karuna Therapeutics.

September 14, 2021

What Is Psycholytic Ketamine Assisted Psychotherapy?

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by returning guest, Vhari Macbeth to discuss psycholytic ketamine-assisted psychotherapy (KAP).

Learn more, subscribe and catch up on previous episodes you may have missed at psychedelictherapyfrontiers.com

View all media

Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial

We are pleased to announce that our wholly owned subsidiary, Cedar Clinical Research has been selected as a research site for a clinical trial sponsored by Karuna Therapeutics, Inc., a clinical-stage neuroscience biopharmaceutical company

The phase III study will evaluate the investigational therapy KarXT for the treatment of schizophrenia, a serious and potentially disabling condition affecting approximately 20 million people worldwide.

Dr. Reid Robison, Novamind’s Chief Medical Officer and Principal Investigator at CCR said, “We need more innovation in this field and I’m hopeful to see compounds like KarXT that have new ways of acting on the brain and the potential for improved efficacy and side effect profiles.”

September 13, 2021

View all press releases

Legalising Illicit Therapies: Why Psychedelics Could Be The Most Important Mental Health Breakthrough Of The 21st Century

As psychedelics continue to break free from the stigma surrounding them, more and more people are seeing the promise these drugs have in changing the way we treat mental health. “Recent trials are showing that psychedelics are proving not only successful but also incredibly effective when stacked up against traditional forms of treatment, with one recent trial reporting that they are up to four times more effective than antidepressants.”

The DEA Seeks To Increase Federal Production Limits For Psilocybin And Marijuana Research

In a big step forward for psychedelic research, the DEA is set to increase limits for psilocybin. From the DEA: “DEA firmly believes in supporting regulated research of schedule I controlled substances.” We look forward to increased research and have a dedicated psychedelic contract research organization (CRO) in Cedar Clinical Research, capable of studying promising new treatments.

Follow @novamind_inc on Instagram

For further information, email us: 
[email protected]

Was this email forwarded to you?
Subscribe to our weekly newsletter

VIDEO – PyroGenesis $6 Million Plasma Torch Order From Major Iron Ore Producer Is Just The Start From Industry In Need Of Reducing GHG Emissions

Posted by AGORACOM-JC at 1:06 PM on Thursday, September 16th, 2021

PyroGenesis $PYR is the world leader in the development of advanced plasma processes and products.  In short, their plasma torch technology has been the foundation of multiple successful applications around the world that significantly reduce both greenhouse gases and costs of doing business for some of the world’s biggest companies in these following verticals: 

  • Ultra High-Tech 3D Printing (Additive Manufacturing)
  • Iron Ore Pelletization
  • Aluminum Smelters Recovery Of Dross
  • High-Purity Silicon For EV Batteries
  • ….. Military Where Their Tech Sits On 4 US Aircraft Carriers.

Today, PyroGenesis announced it’s biggest plasma torch order from one of the world’s largest iron ore producers but – more importantly – sent a strong signal that this is just the beginning of orders that would dwarf today’s order:

  • Today’s $6 Million Plasma Torch Order Represents 4 Torches From Major Iron Ore Pelletizer Client “B”
  • “B” expects next orders to be for 130 torches
  • NPV estimate per torch is now $7M = $910,000,000
  • Client “A” has already requested a cost estimate for 36 torches
  • Discussions with Client “C” and many others are also taking place

HOW BIG IS THE OPPORTUNITY?

“The total world pellet production of 400 million metric tonnes of pellets represents a potential market for torch sales in excess of $10B worldwide. For reference, 40 million tonnes of CO 2 represent the combined yearly emissions of 8.7 million US passenger vehicles”

Watch our great interview with CEO Peter Pascali.

VIDEO: Fabled Silver Gold $FCO $FBSGF President & CEO Peter Hawley Discusses How Grade is King with Latest High Grade Intercepts $FCO $FBSGF $RDU $KTN $GMBXF $EDR

Posted by AGORACOM-Eric at 10:06 PM on Saturday, September 11th, 2021

Fabled Silver Gold (FCO TSXV) ( FBSGF: OTC ) controls 100% of the Santa Maria mine gold and silver property in Mexico.

It is a high grade silver gold property that is situated right in the middle of the Mexican Epithermal silver gold belt that has reportedly produced more silver than any other equivalent area in the entire planet.

To say it’s a mining friendly jurisdiction is an understatement.

Multiple major operators are in the vicinity and Santa Maria already has a silver equivalent 43-101 of 3.2m ounces, but is adding to that not only in tonnage, but in grade. High grade; and that only improves a future 43-101.

High grade mines pay back Capital costs faster, making them economic and profitable.

Check out these intercepts from the last 4 press releases that include not only high grade silver but a new gold discovery as well:

Aug 17: New Gold System, Hits Lower Feeder, which Returns 580.01 g/t Silver Eq, PLUS 19.90% Lead, 5.18% Zinc and 1.29% Copper

Aug 23rd: Intercepts Gold Bearing Sheeted Vein Structure Over A True Width of 150 Meters

Sept 1st: New High Grade Vein Breccia Outside Santa Maria Structure Boundaries, with Grades High As 1,072.73 g/t Ag Eq and..

Sept: 8th: Fabled Hits Supergene Quartz Breccia Over 1.35 Meters Grading 689.56 g/t Ag Eq

Fabled is intent on proving Santa Maria is bigger and of potentially higher grade than the market understands, and is well on its way. Grade is king an the mines with the best grade get developed first.

Santa Maria is already a proven past producer, the development progress made by Fabled is only increasing the potential re-development, but with potential better economics. Sit back and enjoy as Peter Hawley President & CEO explains the importance of how high grade intercepts improve a mines chance of being developed.

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 8:54 AM on Saturday, September 11th, 2021

A weekly summary of Novamind news and media, including the announcement of our uplisting to the OTCQB Market and much more.

September 7, 2021

Treating Trauma with Psychedelic-Assisted Psychotherapy

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by Hannah Cross to discuss how psychedelic-assisted psychotherapy is used to treat trauma.

August 31, 2021

Treating Eating Disorders with Ketamine-Assisted Psychotherapy

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison discuss how ketamine-assisted psychotherapy is used to treat eating disorders

Learn more, subscribe and catch up on previous episodes you may have missed at psychedelictherapyfrontiers.com

View all media

Novamind Uplists to OTCQB Venture Market

We pleased to announce our common shares have been approved for trading under the ticker symbol “NVMDF” on the OTCQB® Venture Market, a U.S. trading platform operated by the OTC Markets Group, Inc.

“With this listing, we look forward to expanding Novamind’s presence in the U.S. and deepening our relationships with a broad base of institutional and retail investors.” said Yaron Conforti, CEO and Director.

September 9, 2021

Novamind to Present at H.C. Wainwright 23rd Annual Global Investment Conference

CEO and Director, Yaron Conforti, will present the Company’s business model focused on growing a national network of psychiatry clinics and clinical research sites to rapidly scale access to psychedelic medicine.

Learn more about the Conference and register to schedule a one-on-one meeting with Novamind’s management here.

September 8, 2021

View all press releases

The Worldview-Changing Drugs Poised to Go Mainstream

BBC Future covers the experience, culture and future of psychedelics and “what might follow if psychedelics become mainstream.” It’s a popular theme in this week’s roundup: what the world will look like after the psychedelic revolution. “Psychedelics offer something that few other things can: an experience well beyond what our everyday reality could conceive or expect.” With such life changing drugs and therapies becoming available, there’s no doubt the future will look a lot different.

Neurocognitive Effects of Ketamine for Depression Examined

This article delivers more positive news about ketamine and esketamine, which we currently use in our Cedar Psychiatry clinics. Learn more about how we use these powerful drugs here. “Use of ketamine and esketamine for their antidepressant effects does not seem to have harmful neurocognitive effects in individuals with treatment-resistant depression, according to a review published online Aug. 5 in the Harvard Review of Psychiatry.”

Psychedelic Treatments Are Here, But Doctors Aren’t Prepared

Rick Doblin and Jennifer Ouyang Altman lay out the potential risks of not having standardized psychedelic education for providers. It’s a problem that will arise as psychedelics continue to move into the mainstream. It’s one reason why education is such a big component of our mission to increase access to psychedelic medicine. On the Psychedelic Therapy Frontiers podcast, we cover topics across the spectrum from trip-sitting to treating trauma with psychedelic-assisted psychotherapy. Another way we’re helping address this issue is by creating psychedelic treatment protocols, sharing best-in-class techniques and procedures with the wider population. Learn more here.

Follow @novamind_inc on Instagram

For further information, email us: 
[email protected]

Was this email forwarded to you?
Subscribe to our weekly newsletter

VIDEO – Biomind Labs (BMND : NEO) Is Developing The Next Generation of Medicines For The 21st Century – The Pharmaceutical Side of Psychedelics

Posted by AGORACOM-JC at 4:40 PM on Wednesday, August 25th, 2021
Biomind Labs Inc. Completes Reverse Take-Over Transaction | Business Wire

Alejandro Antalich, CEO of Biomind. “We, both, are driven by innovation. At Biomind, our objective is to change the course of medicine by assisting doctors in potentially saving more lives and providing a better quality of life to millions of people suffering from addiction, chronic pain, depression, anxiety, and other mental health disorders.

Biomind Labs is Developing the next generation of medicines for the 21st century … the pharmaceutical side of psychedelics

THE PROBLEM

● Depression and anxiety cost the global economy US$ 1 trillion each year

  • ~ 20% of the world’s children and adolescents have a mental health condition
  • Suicide is the second leading cause of death among 15-29 year-olds
  • 13% rise in mental health conditions & substance use disorders in last decade (to 2017)
  • Mental health conditions now cause 1 in 5 years lived with disability

#Psychedelics are going to go through a parabolic, paradigm shifting growth in the next 5 years because of their ability to treat anxiety and depression amongst other things

More than 80% of the global population prefers natural products as sources of new drug candidates …

and that is good because Biomind’s vertical integration approach – Transforming natural psychotropic compounds into pharmaceuticals  – creating drug therapies that harness the medicinal power of natural psychedelic compounds

1 indication is already in Phase 2 … 3 indications in Phase 2 by end 2021 … 3 in Phase 3 by end 2022.

Sit back, relax and watch this powerful interview with Alejandro Antalich, Chief Executive Officer of Biomind Labs.

VIDEO – KIDOZ Co-CEOs Talk Impressive Q2 Revenue Growth Up 196% To $2.18M

Posted by AGORACOM-JC at 4:03 PM on Tuesday, August 24th, 2021

Kidoz owns the biggest mobile advertising platform for kids and families. How big? There are almost 4,000 apps around the world using Kidoz, reaching over 300 MILLION kids. The company works with top brands, including Disney, McDonald’s, Hasbro, and Lego, and is a trusted partner of Apple and Google. 

We sat down with Kidoz Inc. Co-CEOs Jason Williams & Eldad Ben Tora to discuss their stunning Q2 growth, and more.

Q2 2021 highlights include:

  • Total Revenue of $2,177,505 – growth of 196% compared to Q2 2020 Total Revenue of $736,827.
  • AdTech revenue of $2,120,500 – growth of 247% compared to Q2 2020 AdTech Revenue $611,709.
  • Gross Profit of $1,024,333 – growth of 214% compared to Q2 2020 Gross Profit of $325,769.
  • EBITDA of $48,079 a 124% improvement from an EBITDA loss of ($197,057) in Q2 2020.

Sit back, relax and watch this powerful interview.

VIDEO: Candente Copper $DNT.ca Executing The Strategy To Develop The 7.5B Pound Canariaco Deposit $FCX.ca $TECK.ca $FSUGY $PER.ca

Posted by AGORACOM-Eric at 4:18 PM on Thursday, July 29th, 2021
http://blog.agoracom.com/wp-content/uploads/2020/08/candente-copper-for-blog1.jpg

TSX listed Candente Copper owns Canariaco Norte, a large, economic copper deposit in Peru that continues to advance technically and economically.

Cañariaco is a 100% owned feasibility-stage porphyry copper deposit containing 7.5B pounds Measured and Indicated and can be mined for 22 years once in production. Oh, and Canariaco Norte is in the lowest quartile of production costs for projects waiting to be developed at around 0.98c per pound of copper. If that doesn’t have your attention, Goldman Sachs has it ranked as one of the top 80 projects waiting to be developed worldwide.

This is a deposit itching to become a mine and Candente continues to advance the project forward with studies evaluating various methodologies to reduce CAPEX with multiple scenarios that support developing Canariaco closer to a production scenario.

With the price of copper firmly above $4 dollars, the economics supporting Canariaco going into production only gets stronger.

Watch this great interview with Candente CEO Joanne Freeze as she explains how Candente can accelerate the development of Canariaco through the various studies that support a production scenario.

VIDEO: Fabled Silver Gold $FCO $FBSGF Increase Drill Program Beyond 14,000m with New High Grade Gold Discovery in Mexico $FCO $FBSGF $RDU $KTN $GMBXF $EDR

Posted by AGORACOM-Eric at 4:36 PM on Wednesday, July 28th, 2021
This image has an empty alt attribute; its file name is FCO-square-Logo-70x70-1.jpg

Fabled Silver Gold (TSXV:FCO ) (OTCQB: FBSGF) controls 100% of the Santa Maria mine gold and silver property in Mexico. It is a high grade silver gold property that is situated right in the middle of the Mexican Epithermal silver gold belt that has reportedly produced more silver than any other equivalent area in the entire planet.

To say it’s a mining friendly jurisdiction is an understatement.

Multiple major operators are in the vicinity and it’s already got a silver equivalent 43-101 of 3.2m ounces, but is looking to add to that significantly with recent intercepts of 2269 g/t silver.

That is not a typo, in other words it is also 2.269 kilos AgEq or 72 troy ounce. Just recently, Fabled encountered a new, previously unknown gold zone with the discovery of a high grade gold system with values up 10.85 g/t Au within 30.7m grading 161.09 Ag Eq, and the latest assays show 22 g/t gold in a discovery that increases the mineralization beyond known areas, and is open in all directions.   Fabled is moving from high grade silver into a more gold rich environment that includes silver


This quote from Peter J. Hawley, CEO and President describes the discovery:

……“ ‘As a result of discovering this new gold domain system, and ongoing interpretation of structural controls, assays results to date, and visual examination of recently drilled holes we have immediately expanded the present drilling by 5,000 meters, to a total of 14,200 meters. This will ensure that we have significant meterage to properly evaluate this gold discovery.’……..” we continue to define a new, never discovered high grade gold mineral domain system, with silver credits, over consistent widths in an area never explored, and which remains open to the west and at depth, plunging 45 degrees to the west and open in all directions for expansion.

Fabled is intent on proving Santa Maria is bigger and of potentially higher grade than the market understands and is well on its way as the deposit appears to be developing at depth into a dominant high grade gold system.

Sit back and enjoy as Peter Hawley President & CEO explains the importance of increasing the drill program beyond 14,000m and how expanding exploration will continue to yield discoveries.